Laboratorios Farmaceuticos Rovi S.A
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Trypti… Read more
Market Cap & Net Worth: Laboratorios Farmaceuticos Rovi S.A (LABFF)
Laboratorios Farmaceuticos Rovi S.A (PINK:LABFF) has a market capitalization of $4.63 Billion ($4.63 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #5812 globally and #3371 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laboratorios Farmaceuticos Rovi S.A's stock price $90.61 by its total outstanding shares 51149498 (51.15 Million).
Laboratorios Farmaceuticos Rovi S.A Market Cap History: 2020 to 2025
Laboratorios Farmaceuticos Rovi S.A's market capitalization history from 2020 to 2025. Data shows growth from $2.38 Billion to $4.63 Billion (16.59% CAGR).
Laboratorios Farmaceuticos Rovi S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laboratorios Farmaceuticos Rovi S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.07x
Laboratorios Farmaceuticos Rovi S.A's market cap is 6.07 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
33.86x
Laboratorios Farmaceuticos Rovi S.A's market cap is 33.86 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.38 Billion | $419.96 Million | $61.06 Million | 5.67x | 38.98x |
| 2021 | $3.34 Billion | $648.68 Million | $153.08 Million | 5.15x | 21.83x |
| 2022 | $2.48 Billion | $817.70 Million | $199.67 Million | 3.04x | 12.44x |
| 2023 | $2.59 Billion | $829.51 Million | $170.34 Million | 3.13x | 15.22x |
| 2024 | $4.63 Billion | $763.75 Million | $136.88 Million | 6.07x | 33.86x |
Competitor Companies of LABFF by Market Capitalization
Companies near Laboratorios Farmaceuticos Rovi S.A in the global market cap rankings as of March 18, 2026.
Key companies related to Laboratorios Farmaceuticos Rovi S.A by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Laboratorios Farmaceuticos Rovi S.A Historical Marketcap From 2020 to 2025
Between 2020 and today, Laboratorios Farmaceuticos Rovi S.A's market cap moved from $2.38 Billion to $ 4.63 Billion, with a yearly change of 16.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $4.63 Billion | 0.00% |
| 2024 | $4.63 Billion | +78.75% |
| 2023 | $2.59 Billion | +4.40% |
| 2022 | $2.48 Billion | -25.67% |
| 2021 | $3.34 Billion | +40.38% |
| 2020 | $2.38 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Laboratorios Farmaceuticos Rovi S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.63 Billion USD |
| MoneyControl | $4.63 Billion USD |
| MarketWatch | $4.63 Billion USD |
| marketcap.company | $4.63 Billion USD |
| Reuters | $4.63 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.